Old Hands Making New Discoveries
Old Hands Making New Discoveries
Strameno Ltd., Salisbury, Wiltshire, United Kingdom and AlgiSys Biosciences Inc. Cleveland, Ohio, USA today announced that they have entered a Memorandum of Understanding.
Strameno and AlgiSys are both working at the cutting edge of algae technologies, which can have significant impacts on human and animal health while addressing the catastrophic problem of overfishing. The partnership will enable both companies to leverage their complementary expertise and knowledge by creating new products to supply an ever-expanding market for omega-3s, antioxidants, and plant protein.
Dr. Lydia Brown, Strameno Director, noted: “We’re excited to be working with AlgiSys. Our expertise in DHA and niche algae strains combined with AlgiSys expertise in algae commercialization and fermentation technology will help us scale and reach an increasingly wider audience of consumers interested in the many nutritional and health benefits of algal ingredients and products.”
Dr. Charles Roe, AlgiSys CTO, added: “Strameno’s deep knowledge and expertise in microalgae and DHA is unparalleled. Their ultra-high DHA strain of microalgae is a perfect complement to our fermentable strains of microalgae containing EPA omega-3. Working with their team will allow us to expand beyond EPA into carotenoids and DHA for all our targeted vertical markets.”
Strameno Ltd. was created in 2018 to commercialize science that was started decades earlier. The company was founded by a team of scientists working with Strameno’s patented strains of microalgae found in the marine environments of the UK and Scotland. Very little was known about these organisms, which were independently and continuously sub-cultured for their omega-3 and carotenoid content. Strameno is working to develop these strains, which have great potential for algal oils and other important algae-based products. https://www.strameno.com
AlgiSys BioSciences, Inc. is a disruptive BioFoodTech company with patented microalgae-based omega-3 and protein solutions for multiple high-growth markets. AlgiSys uses commercial fermentation technology to sustainably produce non-GMO, halal, vegan, EPA Omega-3s and plant protein. AlgiSys’ all-natural products are a traceable and a complete technology solution that can replace fish oil and fishmeal as a source for human nutrition, pet and animal health, aquaculture, cosmetics, and pharmaceuticals. https://www.algisys.com
For further information:
Strameno – Dr. Lydia Brown – admin@strameno.com
AlgiSys BioSciences – Roger Frank – roger.frank@algisys.com
We’re very pleased to announce that we have been granted a GB patent for our novel organism Caledochytrium aldermanii.
You can find out all about it here:
https://www.ipo.gov.uk/p-ipsum/Case/PublicationNumber/GB2571506
It has been a long road but we are happy to finally have reached this point.
A full, illustrated scientific description is in the final stages of preparation for publication. An author’s copy of this will be posted on ResearchGate, as soon as possible.
Onwards and upwards!!
As we continue working with partners around the world to commercialise our novel isolates we welcome two colleagues to Strameno Ltd.
Strameno Ltd has appointed Professor Simon John Davies FRSB FIAS as Technical Consultant.
Simon J Davies is a long-standing colleague and friend to Strameno’s Directors and is a renowned expert in aquaculture nutrition.
He has worked internationally for a number of years and has held Chairs at Plymouth, Harper Adams, and now as adjunct Professor at University College Galway.
He is also the Editor-in-Chief of International Aquafeed trade magazine since 2009.
Simon has authored over 200 scientific papers, book chapters and commercial reports and was recently appointed a Fellow of the Royal Society of Biology and a Fellow of the Institution of Aquaculture, Singapore. He has advised many government agencies and grant awarding bodies, and acted as a consultant to numerous commercial companies in biotechnology and the feed industry.
Simon joins us specifically for his expertise on thraustochytrids and we welcome him to Strameno.
We also welcome Glynis Leadbetter as Quality and Technical Adviser. Glynis spends most of her time with us in our lab developing our routine and research culture processes and overseeing the quality control aspects of our operation.
Glynis started her career at the Edinburgh University Bacteriology Department, where she worked in research and on the development of the Virology Service. She was involved in the integration of the Edinburgh University Virology, Hepatitis and HIV Reference Laboratory and the Regional Virus Laboratories at the City Hospital to provide a service for the Lothians. She was also involved in the planning and move to the new laboratories at the new Royal Infirmary of Edinburgh in 2002. This presented all laboratory services with an opportunity to share facilities, to meet the ever-increasing requirements of automation and PCR.
Glynis has already made a major contribution to our work and we are delighted to formally welcome her to Strameno
For further information please email: admin@strameno.com
Strameno Limited have recently located their laboratory and office to the Moredun Research Institute (MRI) within the Pentlands Science Park just outside Edinburgh, Scotland.
Research within the MRI’s Aquaculture Division – and planned within Moredun Scientific – complements Strameno’s work on potential feed additives for fish, other animals and people derived from the thraustochytrids. These are protists but are most commonly known as oil-producing micro-algae.
‘Our new facilities will enable us to continue the development of our high yielding protist strains and to expand into different types of related investigations, as well as retaining our strong collaboration with other institutions around the world ’ says Jane Polglase Scientific Director at Strameno Limited.
Information
Strameno Ltd was formed in 2018 to commercialise marine protists (patents applied for) in their collection.
Contact admin@strameno.com
Moredun Research Institute
Moredun Research Institute conducts internationally recognised research on the infectious diseases of livestock, caused by important viruses, bacteria and parasites. It employs 170 scientists, vets and support staff who continue to help find solutions for major challenges to modern farming such as: the consequences of a changing climate, ensuring safe and sustainable food and water supplies, conserving biodiversity, and finding solutions to infectious disease. Today, many of the veterinary medicines and vaccines that are routinely used on farm have either been researched, developed or tested at Moredun. More information about the work of Moredun Research Institute can be found at www.moredun.ac.uk
Pentlands Science Park:
Pentlands Science Park is the much-admired home of the Moredun Group. Set in beautifully landscaped surroundings, PSP also provides an excellent supported environment for over 20 commercial tenants involved in R&D in life sciences and their activities. At the leading edge of the flourishing life sciences community, PSP is a proud partner of the Midlothian Science Zone.
Other parts of the Midlothian Science Zone, include the Easter Bush Campus of the University of Edinburgh, the Biocampus (Scotland’s first dedicated national bio-manufacturing campus) and the Edinburgh Technopole. The Easter Bush Research Consortium (EBRC), includes MRI, the Roslin Institute and Scotland’s Rural University College.